BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi S, Qin M, Cai Y, Liu T, Shen B, Yang F, Cao S, Liu X, Xiang Y, Zhao Q, Huang H, Yang B, Huang C. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. Eur Heart J 2020;41:2070-9. [PMID: 32391877 DOI: 10.1093/eurheartj/ehaa408] [Cited by in Crossref: 204] [Cited by in F6Publishing: 188] [Article Influence: 102.0] [Reference Citation Analysis]
Number Citing Articles
1 Uriel N, Sayer G, Clerkin KJ. Myocardial Injury in COVID-19 Patients: The Beginning or the End? J Am Coll Cardiol 2020;76:547-9. [PMID: 32731932 DOI: 10.1016/j.jacc.2020.06.045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Colombo C, Garatti L, Ferrante G, Casadei F, Montalto C, Crimi G, Cogliati C, Ammirati E, Savonitto S, Morici N. Cardiovascular injuries and SARS-COV-2 infection: focus on elderly people. J Geriatr Cardiol 2021;18:534-48. [PMID: 34404990 DOI: 10.11909/j.issn.1671-5411.2021.07.001] [Reference Citation Analysis]
3 Karagodin I, Carvalho Singulane C, Woodward GM, Xie M, Tucay ES, Tude Rodrigues AC, Vasquez-Ortiz ZY, Alizadehasl A, Monaghan MJ, Ordonez Salazar BA, Soulat-Dufour L, Mostafavi A, Moreo A, Citro R, Narang A, Wu C, Descamps T, Addetia K, Lang RM, Asch FM; WASE-COVID Investigators. Echocardiographic Correlates of In-Hospital Death in Patients with Acute COVID-19 Infection: The World Alliance Societies of Echocardiography (WASE-COVID) Study. J Am Soc Echocardiogr 2021;34:819-30. [PMID: 34023454 DOI: 10.1016/j.echo.2021.05.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Yu JS, Chen RD, Zeng LC, Yang HK, Li H. Myoglobin Offers Higher Accuracy Than Other Cardiac-Specific Biomarkers for the Prognosis of COVID-19. Front Cardiovasc Med 2021;8:686328. [PMID: 34458331 DOI: 10.3389/fcvm.2021.686328] [Reference Citation Analysis]
5 Peiró ÓM, Carrasquer A, Sánchez-Gimenez R, Lal-Trehan N, Del-Moral-Ronda V, Bonet G, Fort-Gallifa I, Picó-Plana E, Bastón-Paz N, Gutiérrez C, Bardaji A. Biomarkers and short-term prognosis in COVID-19. Biomarkers 2021;26:119-26. [PMID: 33426934 DOI: 10.1080/1354750X.2021.1874052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
6 Alsaïdi I, De Sousa Santos F, Plard B, Janvier E, Tinland A, Hafni A, Mosnier E. Factors associated with SARS-CoV2 infection and care pathways among the most vulnerable populations living in Marseille: a case control study. BMC Public Health 2021;21:1704. [PMID: 34538240 DOI: 10.1186/s12889-021-11716-6] [Reference Citation Analysis]
7 Zhang Y, Coats AJ, Zheng Z, Adamo M, Ambrosio G, Anker SD, Butler J, Xu D, Mao J, Khan MS, Bai L, Mebazaa A, Ponikowski P, Tang Q, Ruschitzka F, Seferovic P, Tschöpe C, Zhang S, Gao C, Zhou S, Senni M, Zhang J, Metra M. Management of heart failure patients with COVID ‐19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2020;22:941-56. [DOI: 10.1002/ejhf.1915] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 19.0] [Reference Citation Analysis]
8 Yang L, Xu D, Tan Y, Li B, Zhu D, Wang J, Sun H, Liu X, Zheng X, Zhu L, Li Z. Association Between the Concentration and Rangeability of Cystatin C and Mortality of COVID-19 Patients With or Without Type 2 Diabetes Mellitus: A Retrospective Analysis. Front Endocrinol (Lausanne) 2021;12:642452. [PMID: 34234738 DOI: 10.3389/fendo.2021.642452] [Reference Citation Analysis]
9 Piazza G, Campia U, Hurwitz S, Snyder JE, Rizzo SM, Pfeferman MB, Morrison RB, Leiva O, Fanikos J, Nauffal V, Almarzooq Z, Goldhaber SZ. Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19. J Am Coll Cardiol 2020;76:2060-72. [PMID: 33121712 DOI: 10.1016/j.jacc.2020.08.070] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 29.5] [Reference Citation Analysis]
10 Panagides V, Vincent F, Weizman O, Jonveaux M, Trimaille A, Pommier T, Cellier J, Geneste L, Marsou W, Deney A, Attou S, Delmotte T, Fauvel C, Ezzouhairi N, Perin B, Zakine C, Levasseur T, Ma I, Chavignier D, Noirclerc N, Darmon A, Mevelec M, Karsenty C, Duceau B, Sutter W, Mika D, Pezel T, Waldmann V, Ternacle J, Cohen A, Bonnet G; Critical COVID-19 France Investigators. History of heart failure in patients with coronavirus disease 2019: Insights from a French registry. Arch Cardiovasc Dis 2021;114:415-25. [PMID: 34099379 DOI: 10.1016/j.acvd.2021.04.003] [Reference Citation Analysis]
11 Jouffroy R, Darmon M, Isnard F, Geri G, Beurton A, Fartoukh M, Tudesq JJ, Nemlaghi S, Demoule A, Azoulay E, Vieillard-Baron A. Impact of prone position in non-intubated spontaneously breathing patients admitted to the ICU for severe acute respiratory failure due to COVID-19. J Crit Care 2021;64:199-204. [PMID: 33990007 DOI: 10.1016/j.jcrc.2021.04.014] [Reference Citation Analysis]
12 Alvarez-Garcia J, Lee S, Gupta A, Cagliostro M, Joshi AA, Rivas-Lasarte M, Contreras J, Mitter SS, LaRocca G, Tlachi P, Brunjes D, Glicksberg BS, Levin MA, Nadkarni G, Fayad Z, Fuster V, Mancini D, Lala A. Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19. J Am Coll Cardiol 2020;76:2334-48. [PMID: 33129663 DOI: 10.1016/j.jacc.2020.09.549] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 23.0] [Reference Citation Analysis]
13 Aidan V, Davido B, Mustafic H, Dinh A, Mansencal N, Fayssoil A. [Cardiovascular disorders in patients infected with 2019 novel coronavirus]. Ann Cardiol Angeiol (Paris) 2021;70:106-15. [PMID: 33642045 DOI: 10.1016/j.ancard.2020.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Liang C, Zhang W, Li S, Qin G. Coronary heart disease and COVID-19: A meta-analysis. Med Clin (Engl Ed) 2021;156:547-54. [PMID: 34109276 DOI: 10.1016/j.medcle.2020.12.021] [Reference Citation Analysis]
15 Calvo-Fernández A, Izquierdo A, Subirana I, Farré N, Vila J, Durán X, García-Guimaraes M, Valdivielso S, Cabero P, Soler C, García-Ribas C, Rodríguez C, Llagostera M, Mojón D, Vicente M, Solé-González E, Sánchez-Carpintero A, Tevar C, Marrugat J, Vaquerizo B. [Markers of myocardial injury in the prediction of short-term COVID-19 prognosis]. Rev Esp Cardiol 2021;74:576-83. [PMID: 33262553 DOI: 10.1016/j.recesp.2020.09.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Dalia T, Lahan S, Ranka S, Acharya P, Gautam A, Goyal A, Mastoris I, Sauer A, Shah Z. Impact of congestive heart failure and role of cardiac biomarkers in COVID-19 patients: A systematic review and meta-analysis. Indian Heart J 2021;73:91-8. [PMID: 33714416 DOI: 10.1016/j.ihj.2020.12.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
17 Li C, Wang DW, Zhao C. Cardiovascular Involvement in Patients with 2019 Novel Coronavirus Disease. J Transl Int Med 2021;9:152-60. [PMID: 34900625 DOI: 10.2478/jtim-2021-0016] [Reference Citation Analysis]
18 Kato S, Ishiwata Y, Aoki R, Iwasawa T, Hagiwara E, Ogura T, Utsunomiya D. Imaging of COVID-19: An update of current evidences. Diagn Interv Imaging 2021;102:493-500. [PMID: 34088635 DOI: 10.1016/j.diii.2021.05.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Gammone MA, D'Orazio N. Review: Obesity and COVID-19: A Detrimental Intersection. Front Endocrinol (Lausanne) 2021;12:652639. [PMID: 33995281 DOI: 10.3389/fendo.2021.652639] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Marian AJ. Current state of vaccine development and targeted therapies for COVID-19: impact of basic science discoveries. Cardiovasc Pathol 2021;50:107278. [PMID: 32889088 DOI: 10.1016/j.carpath.2020.107278] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
21 Hammarsten O, Ljungqvist P, Redfors B, Wernbom M, Widing H, Lindahl B, Salahuddin S, Sammantar R, Jha S, Ravn-Fischer A, Brink M, Gisslen M. The ratio of cardiac troponin T to troponin I may indicate non-necrotic troponin release among COVID-19 patients. Clin Chim Acta 2022;527:33-7. [PMID: 34998858 DOI: 10.1016/j.cca.2021.12.030] [Reference Citation Analysis]
22 Zuin M, Rigatelli G, Bilato C, Zuliani G, Roncon L. Heart failure as a complication of COVID-19 infection: systematic review and meta-analysis. Acta Cardiol 2021;:1-7. [PMID: 34080948 DOI: 10.1080/00015385.2021.1890925] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Kavsak PA, Hammarsten O, Worster A, Smith SW, Apple FS. Cardiac Troponin Testing in Patients with COVID-19: A Strategy for Testing and Reporting Results. Clin Chem 2021;67:107-13. [PMID: 33045044 DOI: 10.1093/clinchem/hvaa225] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
24 Calvo-Fernández A, Izquierdo A, Subirana I, Farré N, Vila J, Durán X, García-Guimaraes M, Valdivielso S, Cabero P, Soler C, García-Ribas C, Rodríguez C, Llagostera M, Mojón D, Vicente M, Solé-González E, Sánchez-Carpintero A, Tevar C, Marrugat J, Vaquerizo B. Markers of myocardial injury in the prediction of short-term COVID-19 prognosis. Rev Esp Cardiol (Engl Ed) 2021;74:576-83. [PMID: 33153955 DOI: 10.1016/j.rec.2020.09.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
25 Bularga A, Chapman AR, Mills NL. Mechanisms of Myocardial Injury in COVID-19. Clin Chem 2021;67:1044-6. [PMID: 34117871 DOI: 10.1093/clinchem/hvab111] [Reference Citation Analysis]
26 Mahamat-Saleh Y, Fiolet T, Rebeaud ME, Mulot M, Guihur A, El Fatouhi D, Laouali N, Peiffer-Smadja N, Aune D, Severi G. Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies. BMJ Open 2021;11:e052777. [PMID: 34697120 DOI: 10.1136/bmjopen-2021-052777] [Reference Citation Analysis]
27 Sharma P, Pradhan A, Vohra S, Sethi R. COVID-19 and Cardiovascular Diseases: Challenges and Solutions. Cardiol Res 2021;12:149-55. [PMID: 34046108 DOI: 10.14740/cr1244] [Reference Citation Analysis]
28 Sandoval Y, Januzzi JL Jr, Jaffe AS. Cardiac Troponin for Assessment of Myocardial Injury in COVID-19: JACC Review Topic of the Week. J Am Coll Cardiol 2020;76:1244-58. [PMID: 32652195 DOI: 10.1016/j.jacc.2020.06.068] [Cited by in Crossref: 100] [Cited by in F6Publishing: 88] [Article Influence: 50.0] [Reference Citation Analysis]
29 van den Heuvel FMA, Vos JL, Koop Y, van Dijk APJ, Duijnhouwer AL, de Mast Q, van de Veerdonk FL, Bosch F, Kok B, Netea MG, Hoogerwerf J, Hoefsloot W, Tjwa ETTL, de Korte CL, van Kimmenade RRJ, Nijveldt R. Cardiac function in relation to myocardial injury in hospitalised patients with COVID-19. Neth Heart J 2020;28:410-7. [PMID: 32643071 DOI: 10.1007/s12471-020-01458-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
30 Melillo F, Napolano A, Loffi M, Regazzoni V, Boccellino A, Danzi GB, Cappelletti AM, Rovere-Querini P, Landoni G, Ingallina G, Stella S, Ancona F, Dagna L, Scarpellini P, Ripa M, Castagna A, Tresoldi M, Zangrillo A, Ciceri F, Agricola E. Myocardial injury in patients with SARS-CoV-2 pneumonia: Pivotal role of inflammation in COVID-19. Eur J Clin Invest 2021;:e13703. [PMID: 34706062 DOI: 10.1111/eci.13703] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Tomasoni D, Inciardi RM, Lombardi CM, Tedino C, Agostoni P, Ameri P, Barbieri L, Bellasi A, Camporotondo R, Canale C, Carubelli V, Carugo S, Catagnano F, Dalla Vecchia LA, Danzi GB, Di Pasquale M, Gaudenzi M, Giovinazzo S, Gnecchi M, Iorio A, La Rovere MT, Leonardi S, Maccagni G, Mapelli M, Margonato D, Merlo M, Monzo L, Mortara A, Nuzzi V, Piepoli M, Porto I, Pozzi A, Sarullo F, Sinagra G, Volterrani M, Zaccone G, Guazzi M, Senni M, Metra M. Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study.Eur J Heart Fail. 2020;22:2238-2247. [PMID: 33179839 DOI: 10.1002/ejhf.2052] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 14.5] [Reference Citation Analysis]
32 Guglin M, Ballut K, Ilonze O, Jones M, Rao R. Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 2020. Heart Fail Rev 2021. [PMID: 34215924 DOI: 10.1007/s10741-021-10129-2] [Reference Citation Analysis]
33 Shafi AMA, Shaikh SA, Shirke MM, Iddawela S, Harky A. Cardiac manifestations in COVID-19 patients-A systematic review. J Card Surg. 2020;35:1988-2008. [PMID: 32652713 DOI: 10.1111/jocs.14808] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 20.5] [Reference Citation Analysis]
34 Megiorni F, Pontecorvi P, Gerini G, Anastasiadou E, Marchese C, Ceccarelli S. Sex-Related Factors in Cardiovascular Complications Associated to COVID-19. Biomolecules 2022;12:21. [DOI: 10.3390/biom12010021] [Reference Citation Analysis]
35 Ishigami J, Kou M, Ding N, Matsushita K. Cardiovascular Disease and Coronavirus Disease 2019: Epidemiology, Management, and Prevention. Curr Epidemiol Rep 2021;:1-8. [PMID: 33425654 DOI: 10.1007/s40471-020-00261-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
36 Wei ZY, Qiao R, Chen J, Huang J, Wang WJ, Yu H, Xu J, Wu H, Wang C, Gu CH, Li HJ, Li M, Liu C, Yang J, Ding HM, Lu MJ, Yin WH, Wang Y, Li KW, Shi HF, Qian HY, Yang WX, Geng YJ. Pre-existing Health Conditions and Epicardial Adipose Tissue Volume: Potential Risk Factors for Myocardial Injury in COVID-19 Patients. Front Cardiovasc Med 2020;7:585220. [PMID: 33505992 DOI: 10.3389/fcvm.2020.585220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Le Maréchal M, Morand P, Epaulard O, Némoz B. COVID-19 in clinical practice: A narrative synthesis. Med Mal Infect 2020;50:639-47. [PMID: 33007400 DOI: 10.1016/j.medmal.2020.09.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Chen L, Hu W, Guo X, Zhao P, Tang J, Gu Y, Huang N, Wang C, Cui A, Zhang D, Hu L, Feng Y, Hu S, Chen M, Duru F, Xiong C. Association of coagulation dysfunction with cardiac injury among hospitalized patients with COVID-19. Sci Rep 2021;11:4432. [PMID: 33627696 DOI: 10.1038/s41598-021-83822-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Huang Z, Huang P, Du B, Kong L, Zhang W, Zhang Y, Dong J. Prevalence and clinical outcomes of cardiac injury in patients with COVID-19: A systematic review and meta-analysis. Nutr Metab Cardiovasc Dis 2021;31:2-13. [PMID: 33229199 DOI: 10.1016/j.numecd.2020.09.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
40 Sanghvi SK, Schwarzman LS, Nazir NT. Cardiac MRI and Myocardial Injury in COVID-19: Diagnosis, Risk Stratification and Prognosis. Diagnostics (Basel) 2021;11:130. [PMID: 33467705 DOI: 10.3390/diagnostics11010130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
41 Fan ZX, Yang J, Zhang J, He C, Wu H, Yang CJ, Zheng T, Ma C, Xiang ZJ, Zhai YH, Jiang J, Qiu SQ. Analysis of influencing factors related to elevated serum troponin I level for COVID-19 patients in Yichang, China.Cardiovasc Diagn Ther. 2020;10:678-686. [PMID: 32968624 DOI: 10.21037/cdt-20-510] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
42 Kelham M, Choudry FA, Hamshere S, Beirne AM, Rathod KS, Baumbach A, Ahluwalia A, Mathur A, Jones DA. Therapeutic Implications of COVID-19 for the Interventional Cardiologist. J Cardiovasc Pharmacol Ther 2021;26:203-16. [PMID: 33331160 DOI: 10.1177/1074248420982736] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Mumoli N, Cei M, Mazzone A, Conte G. Cardiac injury as prognostic value in COVID-19: more remains to be clarified. Intern Emerg Med 2021;16:267-8. [PMID: 33113079 DOI: 10.1007/s11739-020-02540-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Burger AL, Kaufmann CC, Jäger B, Pogran E, Ahmed A, Wojta J, Farhan S, Huber K. Direct cardiovascular complications and indirect collateral damage during the COVID-19 pandemic : A review. Wien Klin Wochenschr 2021;133:1289-97. [PMID: 34671829 DOI: 10.1007/s00508-021-01956-2] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Iacobellis G, Secchi F, Capitanio G, Basilico S, Schiaffino S, Boveri S, Sardanelli F, Corsi Romanelli MM, Malavazos AE. Epicardial Fat Inflammation in Severe COVID-19. Obesity (Silver Spring) 2020;28:2260-2. [PMID: 32862512 DOI: 10.1002/oby.23019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
46 Guimarães PO, de Souza FR, Lopes RD, Bittar C, Cardozo FA, Caramelli B, Calderaro D, Albuquerque CP, Drager LF, Feres F, Baracioli L, Feitosa Filho G, Barbosa RR, Ribeiro HB, Ribeiro E, Alves RJ, Soeiro A, Faillace B, Figueiredo E, Damiani LP, do Val RM, Huemer N, Nicolai LG, Hajjar LA, Abizaid A, Kalil Filho R. High risk coronavirus disease 2019: The primary results of the CoronaHeart multi-center cohort study. Int J Cardiol Heart Vasc 2021;36:100853. [PMID: 34345648 DOI: 10.1016/j.ijcha.2021.100853] [Reference Citation Analysis]
47 Cremer S, Pilgram L, Berkowitsch A, Stecher M, Rieg S, Shumliakivska M, Bojkova D, Wagner JUG, Aslan GS, Spinner C, Luxán G, Hanses F, Dolff S, Piepel C, Ruppert C, Guenther A, Rüthrich MM, Vehreschild JJ, Wille K, Haselberger M, Heuzeroth H, Hansen A, Eschenhagen T, Cinatl J, Ciesek S, Dimmeler S, Borgmann S, Zeiher A; LEOSS study group. Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease. PLoS One 2021;16:e0258684. [PMID: 34673795 DOI: 10.1371/journal.pone.0258684] [Reference Citation Analysis]
48 Wei ZY, Geng YJ, Huang J, Qian HY. Pathogenesis and management of myocardial injury in coronavirus disease 2019. Eur J Heart Fail 2020;22:1994-2006. [PMID: 32683753 DOI: 10.1002/ejhf.1967] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
49 Smilowitz NR, Kunichoff D, Garshick M, Shah B, Pillinger M, Hochman JS, Berger JS. C-reactive protein and clinical outcomes in patients with COVID-19. Eur Heart J 2021;42:2270-9. [PMID: 33448289 DOI: 10.1093/eurheartj/ehaa1103] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
50 Urmeneta Ulloa J, Martínez de Vega V, Salvador Montañés O, Álvarez Vázquez A, Sánchez-Enrique C, Hernández Jiménez S, Sancho García FD, López Ruiz L, Recio Rodríguez M, Pizarro G, Carnevali Ruiz D, Ángel Cabrera J. Cardiac magnetic resonance in recovering COVID-19 patients. Feature tracking and mapping analysis to detect persistent myocardial involvement. Int J Cardiol Heart Vasc 2021;36:100854. [PMID: 34368419 DOI: 10.1016/j.ijcha.2021.100854] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Deng YP, Xie W, Liu T, Wang SY, Wang MR, Zan YX, Meng XB, Deng YQ, Xiong HR, Fu XD. Association of Hypertension with Severity and Mortality in Hospitalized Patients with COVID-19 in Wuhan, China: A Single-centered, Retrospective Study. Arq Bras Cardiol 2021:S0066-782X2021005010205. [PMID: 34287571 DOI: 10.36660/abc.20200733] [Reference Citation Analysis]
52 Medzikovic L, Cunningham CM, Li M, Amjedi M, Hong J, Ruffenach G, Eghbali M. Sex differences underlying preexisting cardiovascular disease and cardiovascular injury in COVID-19. J Mol Cell Cardiol 2020;148:25-33. [PMID: 32835666 DOI: 10.1016/j.yjmcc.2020.08.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
53 Wernhart S, Weihe E, Rassaf T. Reduced physical activity and weight gain are associated with an increase of depressive symptoms during the COVID-19 pandemic. A general practitioners' prospective observational study. JRSM Cardiovasc Dis 2021;10:20480040211047742. [PMID: 34631041 DOI: 10.1177/20480040211047742] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Lazaridis C, Vlachogiannis NI, Bakogiannis C, Spyridopoulos I, Stamatelopoulos K, Kanakakis I, Vassilikos V, Stellos K. Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery. Hellenic J Cardiol 2020;61:381-95. [PMID: 32534109 DOI: 10.1016/j.hjc.2020.05.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
55 Toraih EA, Elshazli RM, Hussein MH, Elgaml A, Amin M, El-Mowafy M, El-Mesery M, Ellythy A, Duchesne J, Killackey MT, Ferdinand KC, Kandil E, Fawzy MS. Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID-19 patients: A meta-regression and decision tree analysis. J Med Virol 2020;92:2473-88. [PMID: 32530509 DOI: 10.1002/jmv.26166] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 15.5] [Reference Citation Analysis]
56 Awortwe C, Cascorbi I. Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions. Pharmacol Res. 2020;161:105250. [PMID: 33059010 DOI: 10.1016/j.phrs.2020.105250] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
57 [DOI: 10.1101/2020.04.12.20062869] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 [DOI: 10.1101/2020.07.12.20151316] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
59 Cao J, Zheng Y, Luo Z, Mei Z, Yao Y, Liu Z, Liang C, Yang H, Song Y, Yu K, Gao Y, Zhu C, Huang Z, Qian J, Ge J. Myocardial injury and COVID-19: Serum hs-cTnI level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease. Theranostics 2020;10:9663-73. [PMID: 32863952 DOI: 10.7150/thno.47980] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
60 Stefanini GG, Chiarito M, Ferrante G, Cannata F, Azzolini E, Viggiani G, De Marco A, Briani M, Bocciolone M, Bragato R, Corrada E, Gasparini GL, Marconi M, Monti L, Pagnotta PA, Panico C, Pini D, Regazzoli D, My I, Kallikourdis M, Ciccarelli M, Badalamenti S, Aghemo A, Reimers B, Condorelli G; Humanitas COVID-19 Task Force. Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19. Heart 2020;106:1512-8. [PMID: 32817312 DOI: 10.1136/heartjnl-2020-317322] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 13.0] [Reference Citation Analysis]
61 Changal K, Veria S, Mack S, Paternite D, Sheikh SA, Patel M, Mir T, Sheikh M, Ramanathan PK. Myocardial injury in hospitalized COVID-19 patients: a retrospective study, systematic review, and meta-analysis. BMC Cardiovasc Disord 2021;21:626. [PMID: 34972516 DOI: 10.1186/s12872-021-02450-3] [Reference Citation Analysis]
62 Zhang Q, Zheng Z, Zhang Y. Association of Myocardial Enzyme Abnormality with Clinical Outcomes of Patients with COVID-19: A Retrospective Study. Dis Markers 2021;2021:3440714. [PMID: 34725560 DOI: 10.1155/2021/3440714] [Reference Citation Analysis]
63 Laganà N, Cei M, Evangelista I, Cerutti S, Colombo A, Conte L, Mormina E, Rotiroti G, Versace AG, Porta C, Capra R, Vacirca V, Vitale J, Mazzone A, Mumoli N. Suspected myocarditis in patients with COVID-19: A multicenter case series. Medicine (Baltimore) 2021;100:e24552. [PMID: 33663062 DOI: 10.1097/MD.0000000000024552] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
64 Ramadan MS, Bertolino L, Marrazzo T, Florio MT, Durante-Mangoni E; The Monaldi Hospital Cardiovascular Infection Study Group. Cardiac complications during the active phase of COVID-19: review of the current evidence. Intern Emerg Med 2021. [PMID: 34046852 DOI: 10.1007/s11739-021-02763-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Ashraf H, Soleimani A, Kazemi saeid A, Sadat Naseri A, Majidi F, Peirovi N, Karbalai Saleh S. Troponin I biomarker as a strong prognostic factor for predicting COVID-19 mortality: A systematic review. World J Meta-Anal 2021; 9(4): 342-352 [DOI: 10.13105/wjma.v9.i4.342] [Reference Citation Analysis]
66 Liu J, Chen Y, Li R, Wu Z, Xu Q, Li Z, Annane D, Feng H, Huang S, Guo J, Zhang L, Ye X, Zhu W, Du H, Liu Y, Wang T, Chen L, Wen Z, Teboul JL, Chen D. Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multicentre study. Clin Microbiol Infect 2021:S1198-743X(21)00234-2. [PMID: 34020032 DOI: 10.1016/j.cmi.2021.05.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS, Salazar-Mather TP, Dumenco L, Savaria MC, Aung SN, Flanigan T, Michelow IC. Predictors of COVID-19 severity: A literature review. Rev Med Virol 2021;31:1-10. [PMID: 32845042 DOI: 10.1002/rmv.2146] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 20.0] [Reference Citation Analysis]
68 Gülsen A, König IR, Jappe U, Drömann D. Effect of comorbid pulmonary disease on the severity of COVID-19: A systematic review and meta-analysis. Respirology 2021;26:552-65. [PMID: 33955623 DOI: 10.1111/resp.14049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
69 Turagam MK, Musikantow D, Goldman ME, Bassily-Marcus A, Chu E, Shivamurthy P, Lampert J, Kawamura I, Bokhari M, Whang W, Bier BA, Malick W, Hashemi H, Miller MA, Choudry S, Pumill C, Ruiz-Maya T, Hadley M, Giustino G, Koruth JS, Langan N, Sofi A, Dukkipati SR, Halperin JL, Fuster V, Kohli-Seth R, Reddy VY. Malignant Arrhythmias in Patients With COVID-19: Incidence, Mechanisms, and Outcomes. Circ Arrhythm Electrophysiol 2020;13:e008920. [PMID: 33026892 DOI: 10.1161/CIRCEP.120.008920] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
70 De Michieli L, Ola O, Knott JD, Akula A, Mehta RA, Hodge DO, Dworak M, Yang EH, Gharacholou M, Singh G, Singh R, Gulati R, Jaffe AS, Sandoval Y. High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19. Clin Chem 2021;67:1080-9. [PMID: 33860295 DOI: 10.1093/clinchem/hvab062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Sun W, Zhang Y, Wu C, Wang S, Xie Y, Zhang D, Yuan H, Zhang Y, Cui L, Li M, Zhang Y, Li Y, Wang J, Yang Y, Lv Q, Zhang L, Haines P, Wu WC, Xie M. Early vs. Late Onset Cardiac Injury and Mortality in Hospitalized COVID-19 Patients in Wuhan. Front Cardiovasc Med 2021;8:645587. [PMID: 34124189 DOI: 10.3389/fcvm.2021.645587] [Reference Citation Analysis]
72 Tavazzi G, Corradi F, Mojoli F, Forfori F, Via G. Contextualizing cardiac dysfunction in critically ill patients with COVID-19. Minerva Anestesiol 2020;86:1340-5. [PMID: 33174406 DOI: 10.23736/S0375-9393.20.14859-4] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
73 Vieira MLC, Afonso TR, Oliveira AJ, Stangenhaus C, Dantas JCD, de França LA, Daminelo E, Cordovil A, Martins LAS, Meirelles RAC, Piveta RB, Barros-Gomes S, Aguiar MOD, Roveri PO, Oliveira WA, Lianza AC, Ponchirolli APL, Silva LML, Costa RCPL, Fischer CH, Morhy SS. In-hospital COVID-19 infection echocardiographic analysis: a Brazilian, tertiary single-centre experience. Cardiovasc Ultrasound 2021;19:34. [PMID: 34688300 DOI: 10.1186/s12947-021-00265-y] [Reference Citation Analysis]
74 Luo L, Fu M, Li Y, Hu S, Luo J, Chen Z, Yu J, Li W, Dong R, Yang Y, Tu L, Xu X. The potential association between common comorbidities and severity and mortality of coronavirus disease 2019: A pooled analysis. Clin Cardiol 2020;43:1478-93. [PMID: 33026120 DOI: 10.1002/clc.23465] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 12.5] [Reference Citation Analysis]
75 Lüscher TF. The saga continues: is COVID-19 a cardiopulmonary disease? Eur Heart J 2020;41:2041-4. [PMID: 33216882 DOI: 10.1093/eurheartj/ehaa502] [Reference Citation Analysis]
76 Rafiee MJ, Babaki Fard F, Friedrich MG. COVID-19, myocardial edema and dexamethasone. Med Hypotheses 2020;145:110307. [PMID: 33035967 DOI: 10.1016/j.mehy.2020.110307] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
77 Wang JJ, Edin ML, Zeldin DC, Li C, Wang DW, Chen C. Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities. Pharmacol Ther 2020;215:107628. [PMID: 32653530 DOI: 10.1016/j.pharmthera.2020.107628] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
78 Contessotto P, Pandit A. Therapies to prevent post-infarction remodelling: From repair to regeneration. Biomaterials 2021;275:120906. [PMID: 34139506 DOI: 10.1016/j.biomaterials.2021.120906] [Reference Citation Analysis]
79 Iwasaki M, Saito J, Zhao H, Sakamoto A, Hirota K, Ma D. Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications. Inflammation 2021;44:13-34. [PMID: 33029758 DOI: 10.1007/s10753-020-01337-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
80 Messina F, Giombini E, Montaldo C, Sharma AA, Zoccoli A, Sekaly RP, Locatelli F, Zumla A, Maeurer M, Capobianchi MR, Lauria FN, Ippolito G. Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome. Cell Death Dis 2021;12:788. [PMID: 34385425 DOI: 10.1038/s41419-021-03881-8] [Reference Citation Analysis]
81 Yu JS, Pan NN, Chen RD, Zeng LC, Yang HK, Li H. Cardiac Biomarker Levels and Their Prognostic Values in COVID-19 Patients With or Without Concomitant Cardiac Disease. Front Cardiovasc Med 2020;7:599096. [PMID: 33553255 DOI: 10.3389/fcvm.2020.599096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
82 Xu Q, Samanapally H, Nathala P, Salunkhe V, Furmanek S, Cahill MN, McGuffin T, Mohammad T, Marsili B, Petrey J, Carrico R, Ramirez J, Akca O, Clifford SP, Pahwa S, Roser L, Kong M, Huang J; Center of Excellence for Research in Infectious Diseases (CERID) Coronavirus Study Group on behalf of the COVID-19 CardioVascular Research Group (COVID-CVRG). Outcomes and Risk Factors for Cardiovascular Events in Hospitalized COVID-19 Patients. J Cardiothorac Vasc Anesth 2021:S1053-0770(21)00277-9. [PMID: 33867235 DOI: 10.1053/j.jvca.2021.03.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Xiao K, Yang H, Liu B, Pang X, Du J, Liu M, Liu Y, Jing X, Chen J, Deng S, Zhou Z, Du J, Yin L, Yan Y, Mou H, She Q. Antibodies Can Last for More Than 1 Year After SARS-CoV-2 Infection: A Follow-Up Study From Survivors of COVID-19. Front Med (Lausanne) 2021;8:684864. [PMID: 34336891 DOI: 10.3389/fmed.2021.684864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Zhu F, Li W, Lin Q, Xu M, Du J, Li H. Myoglobin and troponin as prognostic factors in patients with COVID-19 pneumonia. Med Clin (Engl Ed) 2021;157:164-71. [PMID: 34458579 DOI: 10.1016/j.medcle.2021.01.014] [Reference Citation Analysis]
85 Bansal A, Kumar A, Patel D, Puri R, Kalra A, Kapadia SR, Reed GW. Meta-analysis Comparing Outcomes in Patients With and Without Cardiac Injury and Coronavirus Disease 2019 (COVID 19). Am J Cardiol 2021;141:140-6. [PMID: 33217345 DOI: 10.1016/j.amjcard.2020.11.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
86 Liu K, Yang T, Peng XF, Lv SM, Ye XL, Zhao TS, Li JC, Shao ZJ, Lu QB, Li JY, Liu W. A systematic meta-analysis of immune signatures in patients with COVID-19. Rev Med Virol 2021;31:e2195. [PMID: 34260780 DOI: 10.1002/rmv.2195] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
87 Tessitore E, Carballo D, Poncet A, Perrin N, Follonier C, Assouline B, Carballo S, Girardin F, Mach F. Mortality and high risk of major adverse events in patients with COVID-19 and history of cardiovascular disease. Open Heart 2021;8:e001526. [PMID: 33833064 DOI: 10.1136/openhrt-2020-001526] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
88 Huang C, Soleimani J, Herasevich S, Pinevich Y, Pennington KM, Dong Y, Pickering BW, Barwise AK. Clinical Characteristics, Treatment, and Outcomes of Critically Ill Patients With COVID-19: A Scoping Review. Mayo Clin Proc 2021;96:183-202. [PMID: 33413817 DOI: 10.1016/j.mayocp.2020.10.022] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
89 Montone RA, Iannaccone G, Meucci MC, Gurgoglione F, Niccoli G. Myocardial and Microvascular Injury Due to Coronavirus Disease 2019. Eur Cardiol 2020;15:e52. [PMID: 32617121 DOI: 10.15420/ecr.2020.22] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
90 Tsikala Vafea M, Zhang R, Kalligeros M, Mylona EK, Shehadeh F, Mylonakis E. Mortality in mechanically ventilated patients with COVID-19: a systematic review. Expert Rev Med Devices 2021;18:457-71. [PMID: 33836621 DOI: 10.1080/17434440.2021.1915764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Yang L, Jin J, Luo W, Gan Y, Chen B, Li W. Risk factors for predicting mortality of COVID-19 patients: A systematic review and meta-analysis. PLoS One 2020;15:e0243124. [PMID: 33253244 DOI: 10.1371/journal.pone.0243124] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
92 Medranda GA, Brahmbhatt K, Alawneh B, Marzo KP, Schwartz RK, Green SJ. Initial single center ST-segment elevation myocardial infarction experience in New York before and during the COVID-19 pandemic. Cardiovasc Revasc Med 2021:S1553-8389(21)00055-5. [PMID: 33526393 DOI: 10.1016/j.carrev.2021.01.026] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Mueller C, Giannitsis E, Jaffe AS, Huber K, Mair J, Cullen L, Hammarsten O, Mills NL, Möckel M, Krychtiuk K, Thygesen K, Lindahl B; ESC Study Group on Biomarkers in Cardiology of the Acute Cardiovascular Care Association. Cardiovascular biomarkers in patients with COVID-19. Eur Heart J Acute Cardiovasc Care 2021;10:310-9. [PMID: 33655301 DOI: 10.1093/ehjacc/zuab009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
94 Cavaliere F, Biancofiore G, Bignami E, DE Robertis E, Giannini A, Grasso S, Piastra M, Scolletta S, Taccone FS, Terragni P. A year in review in Minerva Anestesiologica 2020: critical care. Minerva Anestesiol 2021;87:124-33. [PMID: 33538419 DOI: 10.23736/S0375-9393.20.15495-6] [Reference Citation Analysis]
95 Palazzuoli A, Ruocco G, Tecson KM, McCullough PA. Screening, detection, and management of heart failure in the SARS-CoV2 (COVID-19) pandemic. Heart Fail Rev 2021;26:973-9. [PMID: 33405001 DOI: 10.1007/s10741-020-10068-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Luo SK, Hu WH, Lu ZJ, Li C, Fan YM, Chen QJ, Chen ZS, Ye JF, Chen SY, Tong JL, Wang LL, Mei J, Lu HY. Diabetes patients with comorbidities had unfavorable outcomes following COVID-19: A retrospective study. World J Diabetes 2021; 12(10): 1789-1808 [PMID: 34754379 DOI: 10.4239/wjd.v12.i10.1789] [Reference Citation Analysis]
97 Tavares CAM, Bailey MA, Girardi ACC. Biological Context Linking Hypertension and Higher Risk for COVID-19 Severity. Front Physiol 2020;11:599729. [PMID: 33329052 DOI: 10.3389/fphys.2020.599729] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Kazemi E, Soldoozi Nejat R, Ashkan F, Sheibani H. The laboratory findings and different COVID-19 severities: a systematic review and meta-analysis. Ann Clin Microbiol Antimicrob 2021;20:17. [PMID: 33726761 DOI: 10.1186/s12941-021-00420-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Fu EL, Janse RJ, de Jong Y, van der Endt VHW, Milders J, van der Willik EM, de Rooij ENM, Dekkers OM, Rotmans JI, van Diepen M. Acute kidney injury and kidney replacement therapy in COVID-19: a systematic review and meta-analysis. Clin Kidney J 2020;13:550-63. [PMID: 32897278 DOI: 10.1093/ckj/sfaa160] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
100 Sinclair JE, Zhu Y, Xu G, Ma W, Shi H, Ma KL, Cao CF, Kong LX, Wan KQ, Liao J, Wang HQ, Arentz M, Redd MA, Gallo LA, Short KR. A meta-analysis on the role of pre-existing chronic disease in the cardiac complications of SARS-CoV-2 infection. iScience 2021;24:102264. [PMID: 33688629 DOI: 10.1016/j.isci.2021.102264] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
101 Huang Y, Hu Z, Hu D, Quan Z, Zhou X, Fan G, Chen X, Liu X, Zhang Z, Chen G, Wu Y, Zhang F, Mao C, Xia H, Liang J, Yang B, Jiang H, Huang C, Barajas-Martínez H, Hu D. Clinical characteristics, risk factors, and cardiac manifestations of cancer patients with COVID-19. J Appl Physiol (1985) 2021;131:966-76. [PMID: 34236244 DOI: 10.1152/japplphysiol.00325.2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Szabó IV, Simon J, Nardocci C, Kardos AS, Nagy N, Abdelrahman RH, Zsarnóczay E, Fejér B, Futácsi B, Müller V, Merkely B, Maurovich-Horvat P. The Predictive Role of Artificial Intelligence-Based Chest CT Quantification in Patients with COVID-19 Pneumonia. Tomography 2021;7:697-710. [PMID: 34842822 DOI: 10.3390/tomography7040058] [Reference Citation Analysis]
103 Sun W, Zhang Y, Wu C, Xie Y, Peng L, Nie X, Yu C, Zheng Y, Li Y, Wang J, Yang Y, Lv Q, Zhang L, Taub CC, Xie M. Incremental prognostic value of biventricular longitudinal strain and high-sensitivity troponin I in COVID-19 patients. Echocardiography 2021;38:1272-81. [PMID: 34184314 DOI: 10.1111/echo.15133] [Reference Citation Analysis]
104 Collinson P. High sensitivity troponin, analytical advantages, clinical benefits and clinical challenges - An update. Clin Biochem 2021;91:1-8. [PMID: 33610525 DOI: 10.1016/j.clinbiochem.2021.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
105 Liang C, Zhang W, Li S, Qin G. Coronary heart disease and COVID-19: A meta-analysis. Med Clin (Barc) 2021;156:547-54. [PMID: 33632508 DOI: 10.1016/j.medcli.2020.12.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
106 Lüscher TF. Understanding COVID-19: in the end it is the endothelium-what else? Eur Heart J 2020;41:3023-7. [PMID: 33216863 DOI: 10.1093/eurheartj/ehaa706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
107 Di Castelnuovo A, Bonaccio M, Costanzo S, Gialluisi A, Antinori A, Berselli N, Blandi L, Bruno R, Cauda R, Guaraldi G, My I, Menicanti L, Parruti G, Patti G, Perlini S, Santilli F, Signorelli C, Stefanini GG, Vergori A, Abdeddaim A, Ageno W, Agodi A, Agostoni P, Aiello L, Al Moghazi S, Aucella F, Barbieri G, Bartoloni A, Bologna C, Bonfanti P, Brancati S, Cacciatore F, Caiano L, Cannata F, Carrozzi L, Cascio A, Cingolani A, Cipollone F, Colomba C, Crisetti A, Crosta F, Danzi GB, D'Ardes D, de Gaetano Donati K, Di Gennaro F, Di Palma G, Di Tano G, Fantoni M, Filippini T, Fioretto P, Fusco FM, Gentile I, Grisafi L, Guarnieri G, Landi F, Larizza G, Leone A, Maccagni G, Maccarella S, Mapelli M, Maragna R, Marcucci R, Maresca G, Marotta C, Marra L, Mastroianni F, Mengozzi A, Menichetti F, Milic J, Murri R, Montineri A, Mussinelli R, Mussini C, Musso M, Odone A, Olivieri M, Pasi E, Petri F, Pinchera B, Pivato CA, Pizzi R, Poletti V, Raffaelli F, Ravaglia C, Righetti G, Rognoni A, Rossato M, Rossi M, Sabena A, Salinaro F, Sangiovanni V, Sanrocco C, Scarafino A, Scorzolini L, Sgariglia R, Simeone PG, Spinoni E, Torti C, Trecarichi EM, Vezzani F, Veronesi G, Vettor R, Vianello A, Vinceti M, De Caterina R, Iacoviello L; COvid-19 RISk and Treatments (CORIST) collaboration. Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study. Nutr Metab Cardiovasc Dis 2020;30:1899-913. [PMID: 32912793 DOI: 10.1016/j.numecd.2020.07.031] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 24.0] [Reference Citation Analysis]
108 Zuin M, Rigatelli G, Bilato C, Zanon F, Zuliani G, Roncon L. Pre-existing atrial fibrillation is associated with increased mortality in COVID-19 Patients. J Interv Card Electrophysiol 2021. [PMID: 33855639 DOI: 10.1007/s10840-021-00992-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Capotosto L, Nguyen BL, Ciardi MR, Mastroianni C, Vitarelli A. Heart, COVID-19, and echocardiography. Echocardiography 2020;37:1454-64. [PMID: 32885490 DOI: 10.1111/echo.14834] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
110 Lin YC, Lai TS, Lin SL, Chen YM, Chu TS, Tu YK. Outcomes of coronavirus 2019 infection in patients with chronic kidney disease: a systematic review and meta-analysis. Ther Adv Chronic Dis 2021;12:2040622321998860. [PMID: 33796245 DOI: 10.1177/2040622321998860] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Hessami A, Shamshirian A, Heydari K, Pourali F, Alizadeh-Navaei R, Moosazadeh M, Abrotan S, Shojaie L, Sedighi S, Shamshirian D, Rezaei N. Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis. Am J Emerg Med 2021;46:382-91. [PMID: 33268238 DOI: 10.1016/j.ajem.2020.10.022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
112 Nascimento JHP, Gomes BFO, Oliveira GMM. Cardiac Troponin as a Predictor of Myocardial Injury and Mortality from COVID-19. Arq Bras Cardiol 2020;115:667-8. [PMID: 33111867 DOI: 10.36660/abc.20200862] [Reference Citation Analysis]
113 Huang TT, Chien YC, Wang CH, Chang SY, Wang JT, Hsieh SC, Yeh YC, Ku SC, Yu CJ, Chiang BL, Chang SC, Tolwani A. Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report. Front Med (Lausanne) 2021;8:649583. [PMID: 34164411 DOI: 10.3389/fmed.2021.649583] [Reference Citation Analysis]
114 Lee AC, Castaneda G, Li WT, Chen C, Shende N, Chakladar J, Taub PR, Chang EY, Ongkeko WM. COVID-19 Severity Potentially Modulated by Cardiovascular-Disease-Associated Immune Dysregulation. Viruses 2021;13:1018. [PMID: 34071557 DOI: 10.3390/v13061018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Larcher R, Besnard N, Akouz A, Rabier E, Teule L, Vandercamere T, Zozor S, Amalric M, Benomar R, Brunot V, Corne P, Barbot O, Dupuy AM, Cristol JP, Klouche K. Admission High-Sensitive Cardiac Troponin T Level Increase Is Independently Associated with Higher Mortality in Critically Ill Patients with COVID-19: A Multicenter Study. J Clin Med 2021;10:1656. [PMID: 33924475 DOI: 10.3390/jcm10081656] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
116 Giustino G, Pinney SP, Lala A, Reddy VY, Johnston-Cox HA, Mechanick JI, Halperin JL, Fuster V. Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia: JACC Focus Seminar. J Am Coll Cardiol 2020;76:2011-23. [PMID: 33092737 DOI: 10.1016/j.jacc.2020.08.059] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 17.5] [Reference Citation Analysis]
117 Pascual-Figal DA. Biochemical or clinical heart failure, not so simple. Eur J Heart Fail 2021;23:465-7. [PMID: 33636054 DOI: 10.1002/ejhf.2128] [Reference Citation Analysis]
118 Karagodin I, Singulane CC, Besser SA, Singh A, Addetia K, DeCara JM, Patel AR, Ward RP, Tung R, Lang RM. Comparison of clinical and echocardiographic features of first and second waves of COVID-19 at a large, tertiary medical center serving a predominantly African American patient population. Int J Cardiovasc Imaging 2021;37:3181-90. [PMID: 34460023 DOI: 10.1007/s10554-021-02393-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Bavishi C, Bonow RO, Trivedi V, Abbott JD, Messerli FH, Bhatt DL. Special Article - Acute myocardial injury in patients hospitalized with COVID-19 infection: A review. Prog Cardiovasc Dis 2020;63:682-9. [PMID: 32512122 DOI: 10.1016/j.pcad.2020.05.013] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 38.5] [Reference Citation Analysis]
120 Lee SC, Son KJ, Han CH, Park SC, Jung JY. Impact of COPD on COVID-19 prognosis: A nationwide population-based study in South Korea. Sci Rep 2021;11:3735. [PMID: 33580190 DOI: 10.1038/s41598-021-83226-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
121 Frangogiannis NG. The significance of COVID-19-associated myocardial injury: how overinterpretation of scientific findings can fuel media sensationalism and spread misinformation. Eur Heart J 2020;41:3836-8. [PMID: 33006608 DOI: 10.1093/eurheartj/ehaa727] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
122 Diaz-Arocutipa C, Carvallo-Castañeda D, Luis-Ybañez O, Pariona M, Rivas-Lasarte M, Álvarez-García J. COVID-19 in heart transplant recipients during February-August 2020: A systematic review. Clin Transplant 2021. [PMID: 34159650 DOI: 10.1111/ctr.14390] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
123 Zwaenepoel B, Dhont S, Hoste E, Gevaert S, Schaubroeck H. The Prognostic Value of Cardiac Biomarkers and Echocardiography in Critical COVID-19. Front Cardiovasc Med 2021;8:752237. [PMID: 34805307 DOI: 10.3389/fcvm.2021.752237] [Reference Citation Analysis]
124 Doyen D, Dupland P, Morand L, Fourrier E, Saccheri C, Buscot M, Hyvernat H, Ferrari E, Bernardin G, Cariou A, Mira JP, Jamme M, Dellamonica J, Jozwiak M. Characteristics of Cardiac Injury in Critically Ill Patients With Coronavirus Disease 2019. Chest 2021;159:1974-85. [PMID: 33129792 DOI: 10.1016/j.chest.2020.10.056] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
125 Alfonso F, Gonzalo N, Rivero F, Escaned J. The year in cardiovascular medicine 2020: interventional cardiology. Eur Heart J 2021;42:985-1003. [PMID: 33448291 DOI: 10.1093/eurheartj/ehaa1096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
126 Capone F, Cipriani A, Molinari L, Poretto A, Sella N, Boscolo A, Campello E, Saller A, Vettor R, Navalesi P, Cattelan AM, Simioni P, Spiezia L. Cardiac injury and COVID-19 associated coagulopathy in patients with acute SARS-CoV-2 pneumonia: A rotational thromboelastometry study. Adv Med Sci 2021;67:39-44. [PMID: 34906908 DOI: 10.1016/j.advms.2021.12.001] [Reference Citation Analysis]
127 Chang WT, Toh HS, Liao CT, Yu WL. Cardiac Involvement of COVID-19: A Comprehensive Review. Am J Med Sci 2021;361:14-22. [PMID: 33187633 DOI: 10.1016/j.amjms.2020.10.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
128 Diab AM, Carleton BC, Goralski KB. COVID-19 pathophysiology and pharmacology: what do we know and how did Canadians respond? A review of Health Canada authorized clinical vaccine and drug trials. Can J Physiol Pharmacol 2021;99:577-88. [PMID: 33852809 DOI: 10.1139/cjpp-2021-0038] [Reference Citation Analysis]
129 Hadzibegovic S, Lena A, Churchill TW, Ho JE, Potthoff S, Denecke C, Rösnick L, Heim KM, Kleinschmidt M, Sander LE, Witzenrath M, Suttorp N, Krannich A, Porthun J, Friede T, Butler J, Wilkenshoff U, Pieske B, Landmesser U, Anker SD, Lewis GD, Tschöpe C, Anker MS. Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings. Eur J Heart Fail 2021. [PMID: 33932255 DOI: 10.1002/ejhf.2210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
130 Zhu F, Li W, Lin Q, Xu M, Du J, Li H. Myoglobin and troponin as prognostic factors in patients with COVID-19 pneumonia. Med Clin (Barc) 2021;157:164-71. [PMID: 33958143 DOI: 10.1016/j.medcli.2021.01.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
131 Franco E, Urosa J, Barakat R, Refoyo I. Physical Activity and Adherence to the Mediterranean Diet among Spanish Employees in a Health-Promotion Program before and during the COVID-19 Pandemic: The Sanitas-Healthy Cities Challenge. Int J Environ Res Public Health 2021;18:2735. [PMID: 33800372 DOI: 10.3390/ijerph18052735] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
132 Hoel H, Heggelund L, Reikvam DH, Stiksrud B, Ueland T, Michelsen AE, Otterdal K, Muller KE, Lind A, Muller F, Dudman S, Aukrust P, Dyrhol-Riise AM, Holter JC, Trøseid M. Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement. J Intern Med 2021;289:523-31. [PMID: 32976665 DOI: 10.1111/joim.13178] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
133 Leung JM, Niikura M, Yang CWT, Sin DD. COVID-19 and COPD. Eur Respir J 2020;56:2002108. [PMID: 32817205 DOI: 10.1183/13993003.02108-2020] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 33.5] [Reference Citation Analysis]
134 Zuin M, Rigatelli G, Zuliani G, Bilato C, Zonzin P, Roncon L. Incidence and mortality risk in coronavirus disease 2019 patients complicated by acute cardiac injury: systematic review and meta-analysis. Journal of Cardiovascular Medicine 2020;21:759-64. [DOI: 10.2459/jcm.0000000000001064] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
135 Nuzzi V, Merlo M, Specchia C, Lombardi CM, Carubelli V, Iorio A, Inciardi RM, Bellasi A, Canale C, Camporotondo R, Catagnano F, Dalla Vecchia LA, Giovinazzo S, Maccagni G, Mapelli M, Margonato D, Monzo L, Oriecuia C, Peveri G, Pozzi A, Provenzale G, Sarullo F, Tomasoni D, Ameri P, Gnecchi M, Leonardi S, Agostoni P, Carugo S, Danzi GB, Guazzi M, La Rovere MT, Mortara A, Piepoli M, Porto I, Volterrani M, Senni M, Metra M, Sinagra G. The prognostic value of serial troponin measurements in patients admitted for COVID-19. ESC Heart Fail 2021. [PMID: 34236135 DOI: 10.1002/ehf2.13462] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
136 Saed Aldien A, Ganesan GS, Wahbeh F, Al-Nassr N, Altarawneh H, Al Theyab L, Saed Aldien S, Tomerak S, Naveed H, Elshazly MB, Zakaria D. Systemic inflammation may induce cardiac injury in COVID-19 patients including children and adolescents without underlying cardiovascular diseases: A systematic review. Cardiovasc Revasc Med 2021:S1553-8389(21)00195-0. [PMID: 33952432 DOI: 10.1016/j.carrev.2021.04.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 Deb S, Arrighi S. Potential Effects of COVID-19 on Cytochrome P450-Mediated Drug Metabolism and Disposition in Infected Patients. Eur J Drug Metab Pharmacokinet 2021;46:185-203. [PMID: 33538960 DOI: 10.1007/s13318-020-00668-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
138 Singh N, Anchan RK, Besser SA, Belkin MN, Cruz MD, Lee L, Yu D, Mehta N, Nguyen AB, Alenghat FJ. High sensitivity Troponin-T for prediction of adverse events in patients with COVID-19.Biomarkers. 2020;25:626-633. [PMID: 32981387 DOI: 10.1080/1354750X.2020.1829056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
139 Marian AJ. Editorial: Cardiovascular complications of COVID-19. Curr Opin Cardiol 2021;36:253-5. [PMID: 33605618 DOI: 10.1097/HCO.0000000000000846] [Reference Citation Analysis]
140 Louw S, Jacobson BF, Mayne ES, Wiggill TM. The Novel Coronavirus and Haemostatic Abnormalities: Pathophysiology, Clinical Manifestations, and Treatment Recommendations. Adv Exp Med Biol 2021;1321:173-80. [PMID: 33656723 DOI: 10.1007/978-3-030-59261-5_15] [Reference Citation Analysis]
141 Liang X, Xu J, Xiao W, Shi L, Yang H. The association of diabetes with COVID-19 disease severity: evidence from adjusted effect estimates. Hormones (Athens) 2021;20:409-14. [PMID: 33236191 DOI: 10.1007/s42000-020-00259-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
142 Sîrbu A, Barbieri G, Faita F, Ferragina P, Gargani L, Ghiadoni L, Priami C. Early outcome detection for COVID-19 patients. Sci Rep 2021;11:18464. [PMID: 34531473 DOI: 10.1038/s41598-021-97990-1] [Reference Citation Analysis]
143 Zhang Y, Sun W, Wu C, Zhang Y, Cui L, Xie Y, Wang B, He L, Yuan H, Zhang Y, Cai Y, Li M, Zhang Y, Yang Y, Li Y, Wang J, Yang Y, Lv Q, Zhang L, Xie M. Prognostic Value of Right Ventricular Ejection Fraction Assessed by 3D Echocardiography in COVID-19 Patients. Front Cardiovasc Med 2021;8:641088. [PMID: 33634177 DOI: 10.3389/fcvm.2021.641088] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
144 Silva Andrade B, Siqueira S, de Assis Soares WR, de Souza Rangel F, Santos NO, Dos Santos Freitas A, Ribeiro da Silveira P, Tiwari S, Alzahrani KJ, Góes-Neto A, Azevedo V, Ghosh P, Barh D. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses 2021;13:700. [PMID: 33919537 DOI: 10.3390/v13040700] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
145 Ruge M, Gomez JMD, du Fay de Lavallaz J, Hlepas A, Rahman A, Patel P, Lavani P, Nair GG, Jahan N, Simmons JA, Rao AK, Williams KA Sr, Volgman AS, Marinescu K, Suboc T. The prognostic value of cardiac troponin for 60 day mortality and major adverse events in COVID-19 patients. Cardiovasc Pathol 2021;55:107374. [PMID: 34358679 DOI: 10.1016/j.carpath.2021.107374] [Reference Citation Analysis]
146 Mesas AE, Cavero-Redondo I, Álvarez-Bueno C, Sarriá Cabrera MA, Maffei de Andrade S, Sequí-Dominguez I, Martínez-Vizcaíno V. Predictors of in-hospital COVID-19 mortality: A comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions. PLoS One 2020;15:e0241742. [PMID: 33141836 DOI: 10.1371/journal.pone.0241742] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 21.5] [Reference Citation Analysis]
147 Ponsford MJ, Burton RJ, Smith L, Khan PY, Andrews R, Cuff S, Tan L, Eberl M, Humphreys IR, Babolhavaeji F, Artemiou A, Pandey M, Jolles SRA, Underwood J. Examining the utility of extended laboratory panel testing in the emergency department for risk stratification of patients with COVID-19: a single-centre retrospective service evaluation. J Clin Pathol 2021:jclinpath-2020-207157. [PMID: 33608408 DOI: 10.1136/jclinpath-2020-207157] [Reference Citation Analysis]
148 Bai Y, Wang E, Zhao S, Li J, Zhu Y, Zhang Y, Cao L, Liu H, Dong Y, Wang F, Liang G, Liu L. Implications of Laboratory Tests in Disease Grading and Death Risk Stratification of COVID-19: A Retrospective Study in Wuhan, China. Front Med (Lausanne) 2021;8:629296. [PMID: 33693017 DOI: 10.3389/fmed.2021.629296] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
149 Ho HT, Peischard S, Strutz-Seebohm N, Klingel K, Seebohm G. Myocardial Damage by SARS-CoV-2: Emerging Mechanisms and Therapies. Viruses 2021;13:1880. [PMID: 34578462 DOI: 10.3390/v13091880] [Reference Citation Analysis]
150 Cremer S, Jakob C, Berkowitsch A, Borgmann S, Pilgram L, Tometten L, Classen A, Wille K, Weidlich S, Gruener B, Dimmeler S, Massberg S, Rieg S, Zeiher AM; LEOSS study group. Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry. Clin Res Cardiol 2021;110:1029-40. [PMID: 33211155 DOI: 10.1007/s00392-020-01769-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
151 Zhan L, Liu Y, Cheng Y, Guo W, Yang J. Predictive Value of Neutrophil/Lymphocyte Ratio (NLR) on Cardiovascular Events in Patients with COVID-19. Int J Gen Med 2021;14:3899-907. [PMID: 34335053 DOI: 10.2147/IJGM.S317380] [Reference Citation Analysis]
152 Jaffe AS, Cleland JGF, Katus HA. Myocardial injury in severe COVID-19 infection. Eur Heart J 2020;41:2080-2. [PMID: 32464642 DOI: 10.1093/eurheartj/ehaa447] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
153 Liu F, Liu F, Wang L. COVID-19 and cardiovascular diseases. J Mol Cell Biol 2021;13:161-7. [PMID: 33226078 DOI: 10.1093/jmcb/mjaa064] [Reference Citation Analysis]
154 Mizera L, Borst O. COVID-19 and the Incidence of Acute Myocardial Injury. Hamostaseologie 2021;41:356-64. [PMID: 34695852 DOI: 10.1055/a-1554-6416] [Reference Citation Analysis]
155 Arnold DT, Attwood M, Barratt S, Morley A, Elvers KT, McKernon J, Donald C, Oates A, Noel A, MacGowan A, Maskell NA, Hamilton FW. Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort study. Emerg Med J 2021;38:543-8. [PMID: 34021028 DOI: 10.1136/emermed-2020-210380] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
156 Khedr EM, Soliman RK, Abo-Elfetof N, Amin M, Mansour OY, Aly A, Zaki AF, Saber M. Clinical and Radiological Characteristics of Acute Cerebrovascular Diseases Among Egyptian Patients With COVID-19 in Upper Egypt. Front Neurol 2021;12:635856. [PMID: 33828521 DOI: 10.3389/fneur.2021.635856] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
157 Adnan G, Shams P, Khan MA, Ali J, Rahman N, Tipoo FA, Samad Z, Fatimi SH, Bukhari S, Faheem O. Impact of COVID-19 on Cardiovascular Disease Presentation, Emergency Department Triage and Inpatient Cardiology Services in a Low- to Middle-Income Country – Perspective from a Tertiary Care Hospital of Pakistan. Global Heart 2021;16:86. [DOI: 10.5334/gh.1084] [Reference Citation Analysis]
158 Prasad A, Panhwar S, Hendel RC, Sheikh O, Mushtaq Z, Dollar F, Vinas A, Alraies C, Almonani A, Nguyen TH, Amione-Guerra J, Foster MT, Sisson C, Anderson A, George JC, Kutkut I, Guareña Casillas JA, Badin A. COVID-19 and the cardiovascular system: A review of current data, summary of best practices, outline of controversies, and illustrative case reports. Am Heart J 2020;226:174-87. [PMID: 32599258 DOI: 10.1016/j.ahj.2020.06.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
159 Petersen SE, Friedrich MG, Leiner T, Elias MD, Ferreira VM, Fenski M, Flamm SD, Fogel M, Garg R, Halushka MK, Hays AG, Kawel-Boehm N, Kramer CM, Nagel E, Ntusi NAB, Ostenfeld E, Pennell DJ, Raisi-Estabragh Z, Reeder SB, Rochitte CE, Starekova J, Suchá D, Tao Q, Schulz-Menger J, Bluemke DA. Cardiovascular Magnetic Resonance for Patients With COVID-19. JACC Cardiovasc Imaging 2021:S1936-878X(21)00688-4. [PMID: 34656482 DOI: 10.1016/j.jcmg.2021.08.021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
160 Irmak E. COVID-19 disease diagnosis from paper-based ECG trace image data using a novel convolutional neural network model. Phys Eng Sci Med 2022. [PMID: 35020175 DOI: 10.1007/s13246-022-01102-w] [Reference Citation Analysis]
161 Cai R, Zhang J, Zhu Y, Liu L, Liu Y, He Q. Mortality in chronic kidney disease patients with COVID-19: a systematic review and meta-analysis. Int Urol Nephrol 2021;53:1623-9. [PMID: 33389508 DOI: 10.1007/s11255-020-02740-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
162 Long J, Luo Y, Wei Y, Xie C, Yuan J. The effect of cardiovascular disease and acute cardiac injury on fatal COVID-19: a meta-analysis. Am J Emerg Med 2021;48:128-39. [PMID: 33895644 DOI: 10.1016/j.ajem.2021.04.013] [Reference Citation Analysis]
163 Kollias A, Kyriakoulis KG, Destounis A, Stergiou GS, Syrigos K. Cardiac injury and prognosis in COVID-19: Methodological considerations and updated meta-analysis. J Infect 2020;81:e181-2. [PMID: 32562792 DOI: 10.1016/j.jinf.2020.06.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
164 Rabbani G, Shariful Islam SM, Rahman MA, Amin N, Marzan B, Robin RC, Alif SM. Pre-existing COPD is associated with an increased risk of mortality and severity in COVID-19: a rapid systematic review and meta-analysis. Expert Review of Respiratory Medicine 2021;15:705-16. [DOI: 10.1080/17476348.2021.1866547] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
165 Weizman O, Mika D, Cellier J, Geneste L, Trimaille A, Pommier T, Panagides V, Marsou W, Deney A, Attou S, Delmotte T, Ribeyrolles S, Chemaly P, Karsenty C, Giordano G, Gautier A, Chaumont C, Guilleminot P, Sagnard A, Pastier J, Duceau B, Sutter W, Fauvel C, Pezel T, Bonnet G, Cohen A, Waldmann V; Critical COVID-19 France Investigators. Characteristics and impact of cardiovascular comorbidities on coronavirus disease 2019 in women: A multicentre cohort study. Arch Cardiovasc Dis 2021;114:394-406. [PMID: 34154954 DOI: 10.1016/j.acvd.2021.04.002] [Reference Citation Analysis]
166 Khan H, Barbhaiya C. Atrial Fibrillation in COVID-19: Therapeutic Target or Grave Omen? Heart Lung Circ 2021;30:1114-6. [PMID: 34215363 DOI: 10.1016/j.hlc.2021.06.001] [Reference Citation Analysis]
167 Wu X, Deng KQ, Li C, Yang Z, Hu H, Cai H, Zhang C, He T, Zheng F, Wang H, Zhang XA, Caillon A, Yuan Y, Wang X, Xu H, Lu Z. Cardiac Involvement in Recovered Patients From COVID-19: A Preliminary 6-Month Follow-Up Study. Front Cardiovasc Med 2021;8:654405. [PMID: 34055936 DOI: 10.3389/fcvm.2021.654405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
168 Mahat RK, Panda S, Rathore V, Swain S, Yadav L, Sah SP. The dynamics of inflammatory markers in coronavirus disease-2019 (COVID-19) patients: A systematic review and meta-analysis. Clin Epidemiol Glob Health 2021;11:100727. [PMID: 33778183 DOI: 10.1016/j.cegh.2021.100727] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
169 D'Onofrio N, Scisciola L, Sardu C, Trotta MC, De Feo M, Maiello C, Mascolo P, De Micco F, Turriziani F, Municinò E, Monetti P, Lombardi A, Napolitano MG, Marino FZ, Ronchi A, Grimaldi V, Hermenean A, Rizzo MR, Barbieri M, Franco R, Campobasso CP, Napoli C, Municinò M, Paolisso G, Balestrieri ML, Marfella R. Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte. Cardiovasc Diabetol 2021;20:99. [PMID: 33962629 DOI: 10.1186/s12933-021-01286-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
170 Huang B, Yan H, Hu L, Cao G, Wang G, Meng J, Li W, Liu G, Wang J, Le W, Jiang H. The Contribution of Psychological Distress to Resting Palpitations in Patients Who Recovered from Severe COVID-19. Int J Gen Med 2021;14:9371-8. [PMID: 34908866 DOI: 10.2147/IJGM.S334715] [Reference Citation Analysis]
171 Liang X, Shi L, Wang Y, Xiao W, Duan G, Yang H, Wang Y. The association of hypertension with the severity and mortality of COVID-19 patients: Evidence based on adjusted effect estimates. J Infect 2020;81:e44-7. [PMID: 32593655 DOI: 10.1016/j.jinf.2020.06.060] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
172 Abate SM, Mantefardo B, Nega S, Chekole YA, Basu B, Ali SA, Taddesse M. Global burden of acute myocardial injury associated with COVID-19: A systematic review, meta-analysis, and meta-regression. Ann Med Surg (Lond) 2021;68:102594. [PMID: 34336202 DOI: 10.1016/j.amsu.2021.102594] [Reference Citation Analysis]
173 Arnau-Barrés I, Pascual-Dapena A, López-Montesinos I, Gómez-Zorrilla S, Sorlí L, Herrero M, Nogués X, Montero M, Vázquez O, García-Giralt N, Miralles R, Güerri-Fernández R. Prevalence and Prognostic Value of Myocardial Injury in the Initial Presentation of SARS-CoV-2 Infection among Older Adults. J Clin Med 2021;10:3738. [PMID: 34442034 DOI: 10.3390/jcm10163738] [Reference Citation Analysis]
174 Li Y, Ashcroft T, Chung A, Dighero I, Dozier M, Horne M, McSwiggan E, Shamsuddin A, Nair H. Risk factors for poor outcomes in hospitalised COVID-19 patients: A systematic review and meta-analysis. J Glob Health 2021;11:10001. [PMID: 33767855 DOI: 10.7189/jogh.11.10001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
175 Chilazi M, Duffy EY, Thakkar A, Michos ED. COVID and Cardiovascular Disease: What We Know in 2021. Curr Atheroscler Rep 2021;23:37. [PMID: 33983522 DOI: 10.1007/s11883-021-00935-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
176 Faghy MA, Arena R, Stoner L, Haraf RH, Josephson R, Hills AP, Dixit S, Popovic D, Smith A, Myers J, Bacon SL, Niebauer J, Dourado VZ, Babu AS, Maden-Wilkinson TM, Copeland RJ, Gough LA, Bond S, Stuart K, Bewick T, Ashton REM; HL-PIVOT Network. The need for exercise sciences and an integrated response to COVID-19: A position statement from the international HL-PIVOT network. Prog Cardiovasc Dis 2021;67:2-10. [PMID: 33549590 DOI: 10.1016/j.pcad.2021.01.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
177 Kim HJ, Hwang H, Hong H, Yim JJ, Lee J. A systematic review and meta-analysis of regional risk factors for critical outcomes of COVID-19 during early phase of the pandemic. Sci Rep 2021;11:9784. [PMID: 33963250 DOI: 10.1038/s41598-021-89182-8] [Reference Citation Analysis]
178 Briscoe M, Sykes R, Krystofiak T, Peck O, Mangion K, Berry C. Clinical significance of coronavirus disease 2019 in hospitalized patients with myocardial injury. Clin Cardiol 2021;44:332-9. [PMID: 33501708 DOI: 10.1002/clc.23530] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
179 Godoy LC, Goligher EC, Lawler PR, Slutsky AS, Zarychanski R. Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19. CMAJ 2020;192:E1156-61. [PMID: 32816822 DOI: 10.1503/cmaj.201240] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
180 Italia L, Tomasoni D, Bisegna S, Pancaldi E, Stretti L, Adamo M, Metra M. COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae. Front Cardiovasc Med 2021;8:713560. [PMID: 34447795 DOI: 10.3389/fcvm.2021.713560] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
181 Cicco S, Vacca A, Cariddi C, Carella R, Altamura G, Solimando AG, Lauletta G, Pappagallo F, Cirulli A, Stragapede A, Susca N, Grasso S, Ria R. Imaging Evaluation of Pulmonary and Non-Ischaemic Cardiovascular Manifestations of COVID-19. Diagnostics (Basel) 2021;11:1271. [PMID: 34359355 DOI: 10.3390/diagnostics11071271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
182 Tajbakhsh A, Gheibi Hayat SM, Taghizadeh H, Akbari A, Inabadi M, Savardashtaki A, Johnston TP, Sahebkar A. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Rev Anti Infect Ther. 2021;19:345-357. [PMID: 32921216 DOI: 10.1080/14787210.2020.1822737] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
183 Carrizales-Sepúlveda EF, Vera-Pineda R, Flores-Ramírez R, Hernández-Guajardo DA, Pérez-Contreras E, Lozano-Ibarra MM, Ordaz-Farías A. Echocardiographic Manifestations in COVID-19: A Review. Heart Lung Circ 2021;30:1117-29. [PMID: 33715970 DOI: 10.1016/j.hlc.2021.02.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
184 Kaddoura R, Salam AM. Thrombosis Management and Challenges in COVID-19 Patients Presenting with Acute Coronary Syndromes. Heart Views 2020;21:195-208. [PMID: 33688412 DOI: 10.4103/HEARTVIEWS.HEARTVIEWS_143_20] [Reference Citation Analysis]
185 Butt JH, Gerds TA, Schou M, Kragholm K, Phelps M, Havers-Borgersen E, Yafasova A, Gislason GH, Torp-Pedersen C, Køber L, Fosbøl EL. Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study. BMJ Open 2020;10:e044421. [PMID: 33277291 DOI: 10.1136/bmjopen-2020-044421] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 13.5] [Reference Citation Analysis]
186 Izquierdo A, Mojón D, Bardají A, Carrasquer A, Calvo-Fernández A, Carreras-Mora J, Giralt T, Pérez-Fernández S, Farré N, Soler C, Solà-Richarte C, Cabero P, Vaquerizo B, Marrugat J, Ribas N. Myocardial Injury as a Prognostic Factor in Mid- and Long-Term Follow-Up of COVID-19 Survivors. J Clin Med 2021;10:5900. [PMID: 34945196 DOI: 10.3390/jcm10245900] [Reference Citation Analysis]
187 Duerr GD, Heine A, Hamiko M, Zimmer S, Luetkens JA, Nattermann J, Rieke G, Isaak A, Jehle J, Held SAE, Wasmuth JC, Wittmann M, Strassburg CP, Brossart P, Coburn M, Treede H, Nickenig G, Kurts C, Velten M. Parameters predicting COVID-19-induced myocardial injury and mortality. Life Sci 2020;260:118400. [PMID: 32918975 DOI: 10.1016/j.lfs.2020.118400] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
188 de Vries AAF. SARS-CoV-2/COVID-19: a primer for cardiologists. Neth Heart J 2020;28:366-83. [PMID: 32671650 DOI: 10.1007/s12471-020-01475-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
189 Frisoni P, Neri M, D'Errico S, Alfieri L, Bonuccelli D, Cingolani M, Di Paolo M, Gaudio RM, Lestani M, Marti M, Martelloni M, Moreschi C, Santurro A, Scopetti M, Turriziani O, Zanon M, Scendoni R, Frati P, Fineschi V. Cytokine storm and histopathological findings in 60 cases of COVID-19-related death: from viral load research to immunohistochemical quantification of major players IL-1β, IL-6, IL-15 and TNF-α. Forensic Sci Med Pathol 2021. [PMID: 34463916 DOI: 10.1007/s12024-021-00414-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
190 Zhu Z, Wang M, Lin W, Cai Q, Zhang L, Chen D, Liu F, Xiong X, Chu J, Peng J, Chen K. Cardiac biomarkers, cardiac injury, and comorbidities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Immun Inflamm Dis 2021. [PMID: 34405950 DOI: 10.1002/iid3.471] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
191 Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020;17:543-558. [PMID: 32690910 DOI: 10.1038/s41569-020-0413-9] [Cited by in Crossref: 313] [Cited by in F6Publishing: 296] [Article Influence: 156.5] [Reference Citation Analysis]
192 Romero Starke K, Petereit-Haack G, Schubert M, Kämpf D, Schliebner A, Hegewald J, Seidler A. The Age-Related Risk of Severe Outcomes Due to COVID-19 Infection: A Rapid Review, Meta-Analysis, and Meta-Regression.Int J Environ Res Public Health. 2020;17. [PMID: 32824596 DOI: 10.3390/ijerph17165974] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 24.5] [Reference Citation Analysis]
193 Cheng R, Liu C, Yang J, Yang Y, Chen R, Ding X, Gao X, Ke J, Yuan F, He C, Shen Y, Zhang L, Li P, Tan H, Huang L. Sex Differences in the Incidence and Risk Factors of Myocardial Injury in COVID-19 Patients: A Retrospective Cohort Study. Front Physiol 2021;12:632123. [PMID: 33664674 DOI: 10.3389/fphys.2021.632123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Kini A, Cao D, Nardin M, Sartori S, Zhang Z, Pivato CA, Chiarito M, Nicolas J, Vengrenyuk Y, Krishnamoorthy P, Sharma SK, Dangas G, Fuster V, Mehran R. Types of myocardial injury and mid-term outcomes in patients with COVID-19. Eur Heart J Qual Care Clin Outcomes 2021;7:438-46. [PMID: 34458912 DOI: 10.1093/ehjqcco/qcab053] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
195 Collinson PO. Commentary on Gastrointestinal Symptoms Followed by Shock in a Febrile 7-Year-Old Child during the COVID-19 Pandemic. Clin Chem 2021;67:58-9. [PMID: 33418583 DOI: 10.1093/clinchem/hvaa291] [Reference Citation Analysis]
196 Singh S, Desai R, Gandhi Z, Fong HK, Doreswamy S, Desai V, Chockalingam A, Mehta PK, Sachdeva R, Kumar G. Takotsubo Syndrome in Patients with COVID-19: a Systematic Review of Published Cases. SN Compr Clin Med. 2020;1-7. [PMID: 33043251 DOI: 10.1007/s42399-020-00557-w] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
197 Demir OM, Ryan M, Cirillo C, Desai N, Pericao A, Sinclair H, Stylianidis V, Victor K, Alaour B, Jones A, Pavlidis AN, Retter A, Carr-White G, Camporota L, Barrett N, Marber M, Perera D. Impact and Determinants of High-Sensitivity Cardiac Troponin-T Concentration in Patients With COVID-19 Admitted to Critical Care. Am J Cardiol 2021;147:129-36. [PMID: 33617816 DOI: 10.1016/j.amjcard.2021.01.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
198 Murat B, Murat S, Mert KU, Bilgin M, Cavusoglu Y. Clinical characteristics and in-hospital outcomes of COVID-19 patients with history of heart failure: a propensity score-matched study. Acta Cardiol 2021;:1-8. [PMID: 34218753 DOI: 10.1080/00015385.2021.1945765] [Reference Citation Analysis]
199 Pareek M, Singh A, Vadlamani L, Eder M, Pacor J, Park J, Ghazizadeh Z, Heard A, Cruz-Solbes AS, Nikooie R, Gier C, Ahmed ZV, Freeman JV, Meadows J, Smolderen KGE, Lampert R, Velazquez EJ, Ahmad T, Desai NR. Relation of Cardiovascular Risk Factors to Mortality and Cardiovascular Events in Hospitalized Patients With Coronavirus Disease 2019 (from the Yale COVID-19 Cardiovascular Registry). Am J Cardiol 2021;146:99-106. [PMID: 33539857 DOI: 10.1016/j.amjcard.2021.01.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
200 Lim ZJ, Subramaniam A, Ponnapa Reddy M, Blecher G, Kadam U, Afroz A, Billah B, Ashwin S, Kubicki M, Bilotta F, Curtis JR, Rubulotta F. Case Fatality Rates for Patients with COVID-19 Requiring Invasive Mechanical Ventilation. A Meta-analysis. Am J Respir Crit Care Med 2021;203:54-66. [PMID: 33119402 DOI: 10.1164/rccm.202006-2405OC] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 37.0] [Reference Citation Analysis]
201 Nishiga M, Wu JC. Macrophages: Potential Therapeutic Target of Myocardial Injury in COVID-19. Circ Res 2021;129:47-9. [PMID: 34166080 DOI: 10.1161/CIRCRESAHA.121.319446] [Reference Citation Analysis]
202 Cosgun MS. Bilirubin levels as an independent predictor of myocarditis in patients with COVID-19. Egypt Heart J 2021;73:108. [PMID: 34928467 DOI: 10.1186/s43044-021-00234-w] [Reference Citation Analysis]
203 Cerci RJ, Vitola JV, Paez D, Zuluaga A, Bittencourt MS, Sierra-galan LM, Carrascosa P, Campisi R, Gutierrez-villamil C, Peix A, Chambers D, Velez MS, Alvarado CMG, Ventura ACF, Maldonado A, Castanos AP, Diaz TC, Herrera Y, Vasquez MC, Arrieta AA, Mut F, Hirschfeld C, Malkovskiy E, Goebel B, Cohen Y, Randazzo M, Shaw LJ, Williams MC, Villines TC, Better N, Dorbala S, Raggi P, Pascual TNB, Pynda Y, Dondi M, Einstein AJ. O Impacto da COVID-19 no Diagnóstico de Doenças Cardíacas na América Latina Uma Subanálise do INCAPS COVID. Arquivos Brasileiros de Cardiologia 2021. [DOI: 10.36660/abc.20210388] [Reference Citation Analysis]
204 Sanz-Sánchez J, Vrachatis DA, Reimers B, Deftereos SG, Kallikourdis M, Vicenzi M, Giannopoulos G, Giotaki SG, Tousoulis D, Ferrante G, Condorelli G, Stefanini GG. Impact of myocardial injury on mortality in patients with COVID-19: a meta-analysis. Hellenic J Cardiol 2021;62:253-5. [PMID: 32781301 DOI: 10.1016/j.hjc.2020.07.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
205 Chaudhary R, Garg J, Houghton DE, Murad MH, Kondur A, Chaudhary R, Wysokinski WE, McBane RD 2nd. Thromboinflammatory Biomarkers in COVID-19: Systematic Review and Meta-analysis of 17,052 Patients. Mayo Clin Proc Innov Qual Outcomes 2021;5:388-402. [PMID: 33585800 DOI: 10.1016/j.mayocpiqo.2021.01.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
206 Shchendrygina A, Nagel E, Puntmann VO, Valbuena-Lopez S. COVID-19 myocarditis and prospective heart failure burden. Expert Rev Cardiovasc Ther 2021;19:5-14. [PMID: 33119418 DOI: 10.1080/14779072.2021.1844005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
207 Fu L, Liu X, Su Y, Ma J, Hong K. Prevalence and impact of cardiac injury on COVID-19: A systematic review and meta-analysis. Clin Cardiol 2021;44:276-83. [PMID: 33382482 DOI: 10.1002/clc.23540] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
208 Pelà G, Goldoni M, Cavalli C, Perrino F, Tagliaferri S, Frizzelli A, Mori PA, Majori M, Aiello M, Sverzellati N, Corradi M, Chetta A. Long-Term Cardiac Sequelae in Patients Referred into a Diagnostic Post-COVID-19 Pathway: The Different Impacts on the Right and Left Ventricles. Diagnostics (Basel) 2021;11:2059. [PMID: 34829406 DOI: 10.3390/diagnostics11112059] [Reference Citation Analysis]
209 Al Abbasi B, Torres P, Ramos-Tuarez F, Dewaswala N, Abdallah A, Chen K, Abdul Qader M, Job R, Aboulenain S, Dziadkowiec K, Bhopalwala H, Pino JE, Chait RD. Cardiac Troponin-I and COVID-19: A Prognostic Tool for In-Hospital Mortality. Cardiol Res 2020;11:398-404. [PMID: 33224386 DOI: 10.14740/cr1159] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
210 An W, Kang JS, Wang Q, Kim TE. Cardiac biomarkers and COVID-19: A systematic review and meta-analysis. J Infect Public Health 2021;14:1191-7. [PMID: 34416596 DOI: 10.1016/j.jiph.2021.07.016] [Reference Citation Analysis]
211 Gao YD, Ding M, Dong X, Zhang JJ, Kursat Azkur A, Azkur D, Gan H, Sun YL, Fu W, Li W, Liang HL, Cao YY, Yan Q, Cao C, Gao HY, Brüggen MC, van de Veen W, Sokolowska M, Akdis M, Akdis CA. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy 2021;76:428-55. [PMID: 33185910 DOI: 10.1111/all.14657] [Cited by in Crossref: 35] [Cited by in F6Publishing: 54] [Article Influence: 17.5] [Reference Citation Analysis]